The UK approval marks the fourth regulatory approval Valneva has received for its single-shot chikungunya vaccine. The vaccine is currently approved in the United States (U.S.) 2, Europe 3 and Canada ...
UK MHRA grants marketing authorization to Valneva’s chikungunya vaccine, Ixchiq: Saint Herblain, France Thursday, February 6, 2025, 12:00 Hrs [IST] Valneva SE, a specialty vacci ...
Valneva has received Medicines and Healthcare products Regulatory Agency (MHRA) authorisation in the UK for the world’s first - and only - Chikungunya vaccine, IXCHIQ. The single-dose vaccine is ...
The approval is based on IXCHIQ ® 's final pivotal Phase 3 data ... which would represent the first approval in an endemic country. Valneva submitted label extension applications to the U.S ...
The approval is based on IXCHIQ ® 's final pivotal Phase 3 data ... which would represent the first approval in an endemic country. Valneva submitted label extension applications to the U.S. Food and ...
Valneva's Ixchiq vaccine – which was cleared in the EU, the US, and Canada last year – is currently indicated for preventing ...